Floatz logo

Pyridostigmine

Emergence Delirium

Konkuk University Medical CenterSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Emergence Delirium cohort.

Asset / SponsorPhaseRating
PROPOFOL
RenJi Hospital
Phase 4BB
ISOFLURANE
Duke University
Phase 4BB
Clonidine
Insel Gruppe AG, University Hospital Bern
Phase 4BB
Cyclopofol
RenJi Hospital
Phase 4BB
Amantadine
Methodist Rehabilitation Center
Phase 4BB

View all 23 →

Same molecule, other indications

Pyridostigmine is also rated in:

strabismusDormant
BB
Indicative ·
65 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
B
Indicative ·
62 / 100
View asset →
spinal muscular atrophy, type IIIDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →